Endocrine and musculoskeletal abnormalities in patients with Down syndrome

Nature Reviews Endocrinology

Volumn 5, Issue 6, 2009, Pages 327-334

  Hawli, Yousra ^a   Nasrallah, Mona ^a   Fuleihan, Ghada El Hajj ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GROWTH HORMONE; VITAMIN D;

ADOLESCENT; ADULT; AGED; BONE DENSITY; BONE MASS; CALCIUM INTAKE; CHILD; DISEASE PREDISPOSITION; DOWN SYNDROME; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; FEMALE; FRAGILITY FRACTURE; GROWTH RETARDATION; HORMONAL REGULATION; HUMAN; HYPOGONADISM; INFANT; LIVE BIRTH; MALE; MENTAL DEFICIENCY; MUSCLE HYPOTONIA; MUSCULOSKELETAL DISEASE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; METABOLISM; MUSCULOSKELETAL SYSTEM MALFORMATION; PATHOLOGY; PATHOPHYSIOLOGY;

BONE DENSITY; DOWN SYNDROME; ENDOCRINE SYSTEM DISEASES; HUMANS; MUSCULOSKELETAL ABNORMALITIES;

EID: 68949114441     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.80     Document Type: Review

References (70)

1. Frid, C., Drott, P., Lundell, B., Rasmussen, F. & Annerén, G. Mortality in Down's syndrome in relation to congenital malformations. J. Intellect. Disabil. Res. 43, 234-241 (1999).
2. Freeman, S. B. et al. Population-based study of congenital heart defects in Down syndrome. Am. J. Med. Genet. 80, 213-217 (1998).
3. Prasher, V. P. & Krishnan, V. H. R. Age of onset and duration of dementia in people with Down syndrome: integration of 98 reported cases in the literature. Int. J. Geriatr. Psychiatry 8, 915-922 (1993).
4. Cohen, W. I. Current dilemmas in Down syndrome clinical care: celiac disease, thyroid disorders and atlanto-axial instability. Am. J. Med. Genet. C. Semin. Med. Genet. 142, 141-148 (2006).
5. Sepúlveda, S. et al. Low spinal and pelvic bone mineral density among individuals with Down syndrome. Am. J. Ment. Retard. 100, 109-114 (1995).
6. Angelopoulou, N., souftas, v., sakadamis, A. & Mandroukas, K. Bone mineral density in adults with Down's syndrome. Eur. Radiol. 9, 648-651 (1999).
7. Center, J., Beange, H. & Mcelduff, A. People with mental retardation have an increased prevalence of osteoporosis: a population study. Am. J. Ment. Retard. 103, 19-28 (1998).
8. Waller, D. K., Anderson, J. L., Lorey, F. & Cunningham, G. C. risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology 62, 36-41 (2000).
9. Prasher, v. P. Prevalence of thyroid dysfunction and autoimmunity in adults with Down syndrome. Downs Syndr. Res. Pract. 2, 67-70 (1994).
10. Kinnell, H. G., Gibbs, N., Teale, J. D. & smith, J. Thyroid dysfunction in institutionalized Down's syndrome adults. Psychol. Med. 17, 387-392 (1987).
11. Fort, P. et al. Abnormalities of thyroid function in infants with Down syndrome. J. Pediatr. 104, 545-549 (1984).
12. Haddow, J. E. et al. Maternal thyroid during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341, 549-555 (1999).
13. Karlsson, B., Gustafsson, J., Hedov, G., Ivarsson, S. A. & Annerén, G. Thyroid dysfunction in Down syndrome: relation to age and thyroid autoimmunity. Arch. Dis. Child. 79, 242-245 (1998).
14. Sharav, T., Collins, R. M. Jr & Baab, P. J. Growth studies in infants and children with Down syndrome and elevated levels of thyrotropin. Am. J. Dis. Child. 142, 1302-1306 (1988).
15. Tüysüz, B. & Beker, D. B. Thyroid dysfunction in children with Down syndrome. Acta Paediatr. 90, 1389-1393 (2001).
16. Sharav, T., Landau, H., Zadik, Z. & Einarson, T. R. Age-related patterns of thyroid-stimulating hormone response to thyrotropin-releasing hormone stimulation in Down syndrome. Am. J. Dis. Child. 145, 172-175 (1991).
17. Lavard, L., Ranløv, I., Perrild, H., Andersen, O. & Jacobsen, B. B. incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. Eur. J. Endocrinol. 130, 565-568 (1994).
18. Hsiang, Y. H., Berkovitz, G. D., Bland, G. L., Migeon, C. J. & Warren, A. C. Gonadal function in patients with Down syndrome. Am. J. Med. Genet. 27, 449-458 (1987).
19. Sakadamis, A., Angelopoulou, N., Matziari, C., Papameletiou, V. & Souftas, V. Bone mass, gonadal function and biochemical assessment in young men with trisomy 21. Eur. J. Obstet. Gynecol. Reprod. Biol. 100, 208-212 (2002).
20. Benda, C. E. in The Child with Mongolism, 124-129 (Grune and stratton, New York, 1960).
21. Pradhan, M., Dalal, A., Khan, F. & Agrawal, S. Fertility in men with Down syndrome: a case report. Fertil. Steril. 86, 1765.e1-1765.e3 (2006).
22. Bobrow, M., Barby, T., Hajianpour, A., Maxwell, D. & Yau, S. C. Fertility in a male with trisomy 21. J. Med. Genet. 29, 141 (1992).
23. Zühlke, C., Thies, U., Braulke, I., Reis, A. & Schirren, C. Down syndrome and male fertility: PCr-derived fingerprinting, serological and andrological investigations. Clin. Genet. 46, 324-326 (1994).
24. Sara, V. R., Gustavson, K. H., Annerén, G., Hall, K. & Wetterberg, L. Somatomedins in Down's syndrome. Biol. Psychiatry 18, 803-811 (1983).
25. Cronk, C. et al. Growth charts of children with Down syndrome: 1 month to 18 years of age. Pediatrics 81, 102-110 (1988).
26. Castells, S. et al. Hypothalamic versus pituitary dysfunction in Down's syndrome as a cause of growth retardation. J. Intellect. Disabil. Res. 40, 509-517 (1996).
27. Wisniewski, K. E. & Bobinski, M. Hypothalamic abnormalities in Down syndrome. in Progress in clinical and biological research, vol.373, The Morphogenesis of Down Syndrome (ed. epstein, C. J.) 153-167 (wiley-Liss, New York, 1991).
28. Shöenau, E. The functional muscle-bone unit in health and disease. in Paediatric Osteology: Prevention of Osteoporosis-A Paediatric Task? (eds shöenau, e. & Matkovic, v.) 191-202 (elsevier science, singapore, 1998).
29. Morris, A. F., Vaughan, S. E. & Vaccaro, P. Measurements of neuromuscular tone and strength in Down syndrome children. J. Ment. Defic. Res. 26 (Pt 1), 41-46 (1982).
30. Bishop, N. et al. Dual-energy X-ray absorptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 isCD pediatric official positions. J. Clin. Densitom. 11, 29-42 (2008).
31. El-Hajj Fuleihan, G. & Vieth, R. vitamin D insufficiency and musculoskeletal health in children and adolescents. Int. Congr. Ser. 1297, 91-108 (2006).
32. Cabana, M., Capone, G., Fritz, A. & Berkovitz, G. Nutritional rickets in a child with Down syndrome. Clin. Pediatr. (Phila.) 36, 235-237 (1997).
33. George, E. K. et al. High frequency of celiac disease in Down syndrome. J. Pediatr. 128, 555-557 (1996).
34. Zachor, D. A., Mroczek-Musulman, E. & Brown, P. Prevalence of celiac disease in Down syndrome in the United states. J. Pediatr. Gastroenterol. Nutr. 31, 275-279 (2000).
35. Javaid, M. K. & Cooper, C. Prenatal and childhood influences on osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 16, 349-367 (2002).
36. Bachrach, L. K. Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol. Metab. Clin. North Am. 34, 521-535 (2005).
37. Fewtrell, M. S. & British Paediatric & Adolescent Bone Group. Bone densitometry in children assessed by dual X-ray absorptiometry: uses and pitfalls. Arch. Dis. Child. 88, 795-798 (2003).
38. Bolotin, H. H. DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodeling. Bone 41, 138-154 (2007).
39. Gordon, C. et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 isCD pediatric official positions. J. Clin. Densitom. 11, 43-58 (2008).
40. Molgaard, C., Thomsen, B. L., Prentice, A., Cole, T. J. & Michaelsen, K. F. whole body bone mineral content in healthy children and adolescents. Arch. Dis. Child. 76, 9-15 (1997).
41. Högler, W., Briody, J., Woodhead, H. J., Chan, A. & Cowell, C. T. importance of lean mass in the interpretation of total body densitometry in children and adolescents. J. Pediatr. 143, 81-88 (2003).
42. Goulding, A. et al. More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J. Bone Miner. Res. 15, 2011-2018 (2000).
43. Clark, e. M., Ness, A. r., Bishop, N. J. & Tobias, J. H. Association between bone mass and fractures in children: a prospective cohort study. J. Bone Miner. Res. 21, 1489-1495 (2006).
44. Flynn, J., Foley, S. & Jones, G. Can BMD assessed by DXA at age 8 predict fracture risk in boys and girls during puberty? An eight-year prospective study. J. Bone Miner. Res. 22, 1463-1467 (2007).
45. Tyler, C. V., Snyder, C. W. & Zyzanski, S. screening for osteoporosis in communitydwelling adults with mental retardation. Ment. Retard. 38, 316-321 (2000).
46. Baptista, F., Varela, A. & Sardinha, L. Bone mineral density in males and females with and without Down syndrome. Osteoporos. Int. 16, 380-388 (2005).
47. Jaffe, J. S., Timell, A. & Gulanski, B. Prevalence of low bone density in women with developmental disabilities. J. Clin. Densitom. 4, 25-29 (2001).
48. Angelopoulou, N. et al. Bone mineral density and muscle strength in young men with mental retardation (with and without Down syndrome). Calcif. Tissue Int. 66, 176-180 (2000).
49. Guijarro, M. et al. Bone mass in young adults with Down syndrome. J. Intellect. Disabil. Res. 52, 182-189 (2008).
50. Pitetti, K. H., Climstein, M., Mays, M. J. & Barrett, P. J. isokinetic arm and leg strength in Down syndrome: a comparative study. Arch. Phys. Med. Rehabil. 73, 847-850 (1992).
51. Roth, G. M., Sun, B., Greensite, F. S., Lott, I. T. & Dietrich, R. B. Premature aging in persons with Down syndrome. Am. J. Neuroradiol. 17, 1283-1289 (1996).
52. Kao, C. H., Chen, C. C., Wang, S. J. & Yeh, S. H. Bone mineral density in children with Down's syndrome detected by dual photon absorptiometry. Nucl. Med. Commun. 13, 773-775 (1992).
53. Lohiya, G. S., Crinella, F. M., Tan-Figueroa, L., Caires, S. & Lohiya, S. Fracture epidemiology and control in a developmental center. West J. Med. 170, 203-209 (1999).
54. Schrager, S., Kloss, C. & Ju, A. W. Prevalence of fractures in women with intellectual disabilities: a chart review. J. Intellect. Disabil. Res. 51, 253-259 (2007).
55. Warren, M. P. & Chua, A. Appropriate use of estrogen replacement therapy in adolescents and young adults with Turner syndrome and hypopituitarism in light of the women's Health initiative. Growth Horm. IGF Res. 16 (Suppl.), s98-s102 (2006).
56. Ross, J. L. et al. effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome. J. Pediatr. 109, 950-953 (1986).
57. Saenger, P. et al. recommendations for the diagnosis and management of Turner syndrome. J. Clin. Endocrinol. Metab. 86, 3061-3069 (2001). (Pubitemid 32673466)
58. Annerén, G. et al. Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development. Arch. Dis. Child. 80, 334-338 (1999).
59. Torrado, C., Bastian, W., Wisniewski, K. E. & Castells, S. Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone. J. Pediatr. 119, 478-483 (1991).
60. Dawson-Hughes, B. et al. effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med. 337, 670-676 (1997).
61. Chapuy, M. C. et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos ii study. Ostoporos. Int. 13, 257-264 (2002).
62. Viljakainen, H. T. et al. A positive dose-response effect of vitamin D supplementation on sitespecific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention. J. Bone Miner. Res. 21, 836-844 (2006).
63. El Hajj-Fuleihan, G. effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J. Clin. Endocrinol. Metab. 91, 405-412 (2006).
64. Del Arco, C., Riancho, J. A., Luzuriaga, C., González- Macías J. & Flórez J. vitamin D status in children with Down's syndrome. J. Intellect. Disabil. Res. 36, 251-257 (1992).
65. Molteno, C., Smit, I., Mills, J. & Huskisson, J. Nutritional status of patients in a long-stay hospital for people with mental handicap. S. Afr. Med. J. 90, 1135-1140 (2000).
66. Zubillaga, P. et al. effect of vitamin D and calcium supplementation on bone turnover in institutionalized patients with Down syndrome. Eur. J. Clin. Nutr. 60, 605-609 (2006).
67. standing Committee on the scientific evaluation of Dietary reference intakes, Food and Nutrition Board, institute of Medicine. (1991) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. The National Academies Press (online), http://www.nap.edu/html/dri-calcium/ tables.html (accessed 23 April 2009).
68. Misra, M. et al. vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122, 398-417 (2008).
69. Ulrich, B. D., Angulo-Kinzler, R. M. & Yun, J. Treadmill training of infants with Down syndrome: evidence-based developmental outcomes. Pediatrics 108, e84 (2001).
70. Shields, N., Taylor, N. F. & Dodd, K. J. effects of a community-based progressive resistance training program on muscle performance and physical function in adults with Down syndrome: a randomized controlled trial. Arch. Phys. Med. Rehabil. 89, 1215-1220 (2008).